SCM Pharma has bolstered its North American profile with the appointment of a US-based business development manager.
Derek Richards will oversee the UK-based contract development and manufacturing organisation’s (CDMO) business development activities across the region and will be responsible for growing its overall US footprint.
Previously of Aptuit, Novartis and Schering Plough, Richards brings an impressive track record in sterile fill finish and formulation development to his new role.
The move follows US FDA approval for SCM Pharma’s UK-based clinical development and manufacturing facility.
'The minute we knew the FDA were due to inspect our clinical headquarters in Prudhoe, we recognised the need to strengthen our US presence as the approval will no doubt trigger more demand for our small scale clinical and contract manufacturing services in North America,' said Dianne Sharp, Managing Director at SCM Pharma. 'As soon as Derek came on our radar, we knew he was the ideal person for this role.'
SCM Pharma already works with several companies in the US and has built its reputation around the sterile filling of novel products, difficult processes and applications and dangerous substances such as potent products requiring high containment.
